ADPT Competitors & Alternatives
Compare Adaptive Biotechnologies Corp with similar stocks in the same industry
Diagnostics & Research
ADPT
Main Stock$13.88
Tradestie Score
55
Market Cap
$2.22B
Revenue Growth
0.4%
Analyst Upside
+45.1%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$47.31
|
$3.26B | - | 54 | Compare |
|
VCYT
Veracyte, Inc.
|
$45.03
|
$2.85B | 41.8 | 55 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$28.64
|
$2.44B | - | 50 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$67.19
|
$2.24B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$60.57
|
$1.77B | - | 55 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$23.68
|
$1.54B | - | 60 | Compare |
|
NEOG
Neogen Corp
|
$8.90
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.27
|
$1.23B | - | 58 | Compare |
|
NEO
NeoGenomics, Inc.
|
$9.23
|
$1.13B | - | 61 | Compare |
|
CDNA
CareDx, Inc.
|
$21.63
|
$798.40M | - | 52 | Compare |
More ADPT Analysis
Data updated: May 25, 2026 | Industry: Diagnostics & Research (SIC 2836)
36 stocks in this industry